Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 236

1.

[Results of the use of antioxidant and angioprotective agents in type 2 diabetes patients with diabetic retinopathy and age-related macular degeneration].

Moshetova LK, Vorob'eva IV, Alekseev IB, Mikhaleva LG.

Vestn Oftalmol. 2015 May-Jun;131(3):34-44. doi: 10.17116/oftalma2015131334-44. Russian.

PMID:
26310005
2.

Outcomes of intravitreal anti-VEGF therapy in eyes with both neovascular age-related macular degeneration and diabetic retinopathy.

Bandello F, Corvi F, La Spina C, Benatti L, Querques L, Capuano V, Naysan J, Chen X, Sarraf D, Parodi MB, Souied E, Freund KB, Querques G.

Br J Ophthalmol. 2016 Dec;100(12):1611-1616. doi: 10.1136/bjophthalmol-2016-308400. Epub 2016 Mar 7.

PMID:
26951773
3.

[Modern approach to early diagnosis and pathogenetic treatment of diabetic retinopathy].

Vorob'eva IV.

Vestn Oftalmol. 2016;132(5):60-67. doi: 10.17116/oftalma2016132560-67. Russian.

PMID:
27911427
4.

Long-term longitudinal modifications in mesopic microperimetry in early and intermediate age-related macular degeneration.

Vujosevic S, Pucci P, Casciano M, Longhin E, Convento E, Bini S, Midena E.

Graefes Arch Clin Exp Ophthalmol. 2017 Feb;255(2):301-309. doi: 10.1007/s00417-016-3466-z. Epub 2016 Aug 31.

PMID:
27582087
5.

Functional and morphological changes in diabetic macular edema over the course of anti-vascular endothelial growth factor treatment.

Reznicek L, Cserhati S, Seidensticker F, Liegl R, Kampik A, Ulbig M, Neubauer AS, Kernt M.

Acta Ophthalmol. 2013 Nov;91(7):e529-36. doi: 10.1111/aos.12153. Epub 2013 May 7.

6.

Microperimetry and fundus autofluorescence in diabetic macular edema: subthreshold micropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation.

Vujosevic S, Bottega E, Casciano M, Pilotto E, Convento E, Midena E.

Retina. 2010 Jun;30(6):908-16. doi: 10.1097/IAE.0b013e3181c96986.

PMID:
20168272
8.

Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35.

Chew EY, Clemons TE, Agrón E, Sperduto RD, Sangiovanni JP, Kurinij N, Davis MD; Age-Related Eye Disease Study Research Group.

Ophthalmology. 2013 Aug;120(8):1604-11.e4. doi: 10.1016/j.ophtha.2013.01.021. Epub 2013 Apr 10. Erratum in: Ophthalmology. 2016 Dec;123(12 ):2634.

9.

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8.

Age-Related Eye Disease Study Research Group.

Arch Ophthalmol. 2001 Oct;119(10):1417-36. Erratum in: Arch Ophthalmol. 2008 Sep;126(9):1251.

10.

Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.

Age-Related Eye Disease Study 2 Research Group.

JAMA. 2013 May 15;309(19):2005-15. doi: 10.1001/jama.2013.4997. Erratum in: JAMA. 2013 Jul 10;310(2):208.

PMID:
23644932
11.

Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.

Goff MJ, Johnson RN, McDonald HR, Ai E, Jumper JM, Fu A.

Retina. 2007 Apr-May;27(4):432-8.

PMID:
17420694
12.

Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.

Haritoglou C, Kook D, Neubauer A, Wolf A, Priglinger S, Strauss R, Gandorfer A, Ulbig M, Kampik A.

Retina. 2006 Nov-Dec;26(9):999-1005.

PMID:
17151486
13.

A prospective study of treatment patterns and 1-year outcome of Asian age-related macular degeneration and polypoidal choroidal vasculopathy.

Cheung CM, Li X, Mathur R, Lee SY, Chan CM, Yeo I, Loh BK, Williams R, Wong EY, Wong D, Wong TY.

PLoS One. 2014 Jun 30;9(6):e101057. doi: 10.1371/journal.pone.0101057. eCollection 2014.

14.
15.

CFH and ARMS2 genetic polymorphisms predict response to antioxidants and zinc in patients with age-related macular degeneration.

Awh CC, Lane AM, Hawken S, Zanke B, Kim IK.

Ophthalmology. 2013 Nov;120(11):2317-23. doi: 10.1016/j.ophtha.2013.07.039. Epub 2013 Aug 21.

PMID:
23972322
16.

Short-term effects of a single intravitreal bevacizumab injection on retinal vessel calibre.

Tatlipinar S, Dinç UA, Yenerel NM, Görgün E.

Clin Exp Optom. 2012 Jan;95(1):94-8. doi: 10.1111/j.1444-0938.2011.00662.x. Epub 2011 Sep 28.

17.
18.

Diabetic macular edema: correlation between microperimetry and optical coherence tomography findings.

Vujosevic S, Midena E, Pilotto E, Radin PP, Chiesa L, Cavarzeran F.

Invest Ophthalmol Vis Sci. 2006 Jul;47(7):3044-51.

PMID:
16799051
19.

Types of diabetic macular edema assessed by optical coherence tomography.

Koleva-Georgieva DN, Sivkova NP.

Folia Med (Plovdiv). 2008 Jul-Sep;50(3):30-8.

PMID:
19009748
20.

Fundus microperimetry patterns of fixation in type 2 diabetic patients with diffuse macular edema.

Carpineto P, Ciancaglini M, Di Antonio L, Gavalas C, Mastropasqua L.

Retina. 2007 Jan;27(1):21-9.

PMID:
17218911

Supplemental Content

Support Center